James Yaro; Analyst; Goldman Sachs & Company, Inc. Brendan O’Brien; Analyst; Wolfe Research Aidan Hall; Analyst; Keefe, Bruyette & Woods, Inc. Good morning and welcome to the Evercore fourth ...
NEW YORK, January 22, 2025--(BUSINESS WIRE)--Evercore Wealth Management today announced the appointment of Jonathan Kropf as partner and head of the San Francisco office. He is also named a ...
NEW YORK--(BUSINESS WIRE)--Evercore (NYSE: EVR) announced today that David Kamo has joined the firm as a senior managing director to support its growing financial sponsor M&A advisory business ...
Evercore (NYSE: EVR) announced today that David Kamo has joined the firm as a senior managing director to support its growing financial sponsor M&A advisory business,based in New York. “We are ...
Evercore's Q4 2024 EPS of $3.41 beat the forecast of $3.04. Revenue for the quarter reached $975.33 million, surpassing expectations. Stock price increased by 1.82% in premarket trading after the ...
In a report released yesterday, Amit Daryanani from Evercore ISI maintained a Buy rating on Vertiv Holdings (VRT – Research Report), with a price target of $150.00. The company’s shares closed ...
Evercore ISI upgraded CarMax (KMX) to Outperform from In Line with a price target of $110, up from $90. The firm sees the company’s improving comp and share trends persisting amid a favorable ...
Rich Ross, head of technical analysis at Evercore ISI, said that a breakout to an all-time high in the S&P 500 (SP500), (SPX) and the Nasdaq 100 (QQQM), (QQQ) “is imminent.” Ross said he ...
NEW YORK (AP) — NEW YORK (AP) — Evercore Inc. (EVR) on Wednesday reported net income of $140.4 million in its fourth quarter. The company, based in New York, said it had earnings of $3.30 per ...
(RTTNews) - Evercore Inc. (EVR) reported a profit for its fourth quarter that increased from last year and beat the Street estimates. The company's earnings came in at $140.44 million, or $3.30 ...
Fintel reports that on February 14, 2025, Evercore ISI Group upgraded their outlook for CRISPR Therapeutics (BRSE:1CG) from In-Line to Outperform. There are 577 funds or institutions reporting ...
However, citing its channel checks with senior AI engineers at major hyperscalers, Evercore notes that while DeepSeek offers cost improvements, these are seen as “evolutionary rather than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results